BeiGene, Ltd.
USD184.71
+0.90 (+0.49%)
CEO
John V. Oyler
IPO Date
2016-02-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$184.00
Prev. Close
$183.81
Day Low
$183.91
Day High
$187.42
52W Low
$126.97
52W High
$248.16
Market Cap
$20.21B
Volume
0.33M
| -3.6 |
| 31 Dec 2023 | FY | 84.5% | -35.9% | -24.9% | -15.2% | 0.26 | 2.32 | -2.3 |
| 31 Dec 2022 | FY | 79.8% | -141.5% | -45.7% | -31.4% | 0.14 | 3.55 | -1.0 |
| 31 Dec 2021 | FY | 86.0% | -123.9% | -23.4% | -16.9% | 0.11 | 4.76 | -1.4 |
| 31 Dec 2020 | FY | -342.1% | -526.1% | -42.0% | -29.0% | 0.15 | 4.61 | -1.3 |
| 31 Dec 2019 | FY | -133.2% | -221.5% | -97.0% | -58.8% | 0.28 | 4.10 | -1.5 |
| 31 Dec 2018 | FY | -257.0% | -339.9% | -38.4% | -29.9% | 0.11 | 7.89 | -1.9 |
| 31 Dec 2017 | FY | -14.9% | -39.1% | -13.6% | -8.9% | 0.24 | 6.09 | -11.1 |
| 31 Dec 2016 | FY | -9062.0% | -11141.8% | -33.8% | -29.4% | 0.05 | 10.68 | -6.0 |
| 205.0 |
| 30 Sept 2025 | Q3 | 86.1% | 8.8% | 3.0% | 1.6% | 0.25 | 2.39 | 9.5 |
| 30 Jun 2025 | Q2 | 87.5% | 7.2% | 2.5% | 1.5% | 0.27 | 1.95 | 9.2 |
| 31 Mar 2025 | Q1 | 85.2% | 0.1% | 0.0% | 0.0% | 0.28 | 1.96 | 720.1 |
| 31 Dec 2024 | Q4 | 85.4% | -11.8% | -4.2% | -2.4% | 0.32 | 1.80 | -4.2 |
| 30 Sept 2024 | Q3 | 83.3% | -14.7% | -4.5% | -2.6% | 0.32 | 1.93 | -4.4 |
| 30 Jun 2024 | Q2 | 85.1% | -13.0% | -3.6% | -2.1% | 0.32 | 1.98 | -3.4 |
| 31 Mar 2024 | Q1 | 83.4% | -33.4% | -7.5% | -4.4% | 0.32 | 2.08 | -1.8 |
| 31 Dec 2023 | Q4 | 82.6% | -52.1% | -9.5% | -5.8% | 0.26 | 2.32 | -1.5 |